Phage Therapy Beyond Static Pharmaceuticals: A Framework for Controlled Evolutionary Platforms
Rising antimicrobial resistance has revived global interest in phage therapy, yet its transition to standard clinical practice remains slow. This challenge is not solely due to a lack of efficacy. Instead, we face a fundamental conceptual barrier caused by an “evaluation mismatch.” Traditional regul...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2026-05-01
|
| Serie: | Viruses |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/1999-4915/18/5/534 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|